Bactiguard has been informed that the European Patent Office (EPO) intends to grant a European patent for Bactiguard's infection prevention technology. The new patent, which is the third generation, will provide extensive worldwide protection for the Bactiguard technology until 2039.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.6 SEK | +2.32% | +3.22% | +14.24% |
May. 14 | Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors | CI |
Apr. 25 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.24% | 228M | |
+6.84% | 27.04B | |
-40.08% | 2.82B | |
-19.95% | 2.42B | |
+16.30% | 2.32B | |
+7.28% | 2.22B | |
+16.67% | 1.8B | |
-13.56% | 1.8B | |
+18.92% | 1.25B | |
+20.00% | 1.21B |
- Stock Market
- Equities
- BACTI B Stock
- News Bactiguard Holding AB
- Bactiguard Announces European Patent Office Intends to Grant A European Patent for Bactiguard's Infection Prevention Technology